228 related articles for article (PubMed ID: 30229924)
1. Intranasal Corticosteroids Do Not Lead to Ocular Changes: A Systematic Review and Meta-analysis.
Valenzuela CV; Liu JC; Vila PM; Simon L; Doering M; Lieu JEC
Laryngoscope; 2019 Jan; 129(1):6-12. PubMed ID: 30229924
[TBL] [Abstract][Full Text] [Related]
2. Intranasal corticosteroids do not affect intraocular pressure or lens opacity: a systematic review of controlled trials.
Ahmadi N; Snidvongs K; Kalish L; Sacks R; Tumuluri K; Wilcsek G; Harvey R
Rhinology; 2015 Dec; 53(4):290-302. PubMed ID: 26275683
[TBL] [Abstract][Full Text] [Related]
3. Effects of H1 antihistamine addition to intranasal corticosteroid for allergic rhinitis: a systematic review and meta-analysis.
Seresirikachorn K; Chitsuthipakorn W; Kanjanawasee D; Khattiyawittayakun L; Snidvongs K
Int Forum Allergy Rhinol; 2018 Oct; 8(10):1083-1092. PubMed ID: 29917324
[TBL] [Abstract][Full Text] [Related]
4. Effects of double-dose intranasal corticosteroid for allergic rhinitis: a systematic review and meta-analysis.
Khattiyawittayakun L; Seresirikachorn K; Chitsuthipakorn W; Kanjanawasee D; Snidvongs K
Int Forum Allergy Rhinol; 2019 Jan; 9(1):72-78. PubMed ID: 30179317
[TBL] [Abstract][Full Text] [Related]
5. The relationship of intranasal steroids to intraocular pressure.
Bergmann J; Witmer MT; Slonim CB
Curr Allergy Asthma Rep; 2009 Jul; 9(4):311-5. PubMed ID: 19656479
[TBL] [Abstract][Full Text] [Related]
6. Safety of intranasal corticosteroids.
Bensch GW
Ann Allergy Asthma Immunol; 2016 Dec; 117(6):601-605. PubMed ID: 27979016
[TBL] [Abstract][Full Text] [Related]
7. Intranasal antihistamine is superior to oral H
Du K; Qing H; Zheng M; Wang X; Zhang L
Ann Allergy Asthma Immunol; 2020 Nov; 125(5):589-596.e3. PubMed ID: 32650045
[TBL] [Abstract][Full Text] [Related]
8. Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis.
Lohia S; Schlosser RJ; Soler ZM
Allergy; 2013; 68(5):569-79. PubMed ID: 23590215
[TBL] [Abstract][Full Text] [Related]
9. Leukotriene receptor antagonist addition to intranasal steroid: systematic review and meta-analysis.
Seresirikachorn K; Mullol J; Limitlaohaphan K; Asvapoositkul V; Snidvongs K
Rhinology; 2021 Feb; 59(1):2-9. PubMed ID: 32692787
[TBL] [Abstract][Full Text] [Related]
10. Combined medical therapy in the treatment of allergic rhinitis: Systematic review and meta-analyses.
Chitsuthipakorn W; Hoang MP; Kanjanawasee D; Seresirikachorn K; Snidvongs K
Int Forum Allergy Rhinol; 2022 Dec; 12(12):1480-1502. PubMed ID: 35446512
[TBL] [Abstract][Full Text] [Related]
11. The Relationship Between Long-term Use of Intranasal Corticosteroid and Intraocular Pressure.
Mohd Zain A; Md Noh UK; Hussein S; Che Hamzah J; Mohd Khialdin S; Md Din N
J Glaucoma; 2019 Apr; 28(4):321-324. PubMed ID: 30585941
[TBL] [Abstract][Full Text] [Related]
12. Epistaxis Risk Associated with Intranasal Corticosteroid Sprays: A Systematic Review and Meta-analysis.
Wu EL; Harris WC; Babcock CM; Alexander BH; Riley CA; McCoul ED
Otolaryngol Head Neck Surg; 2019 Jul; 161(1):18-27. PubMed ID: 30779679
[TBL] [Abstract][Full Text] [Related]
13. As-needed intranasal corticosteroid spray for allergic rhinitis: a systematic review and meta-analysis.
Hoang MP; Chitsuthipakorn W; Seresirikachorn K; Snidvongs K
Rhinology; 2022 Aug; 60(4):242-251. PubMed ID: 35379997
[TBL] [Abstract][Full Text] [Related]
14. Effects of decongestant addition to intranasal corticosteroid for chronic rhinitis: a systematic review and meta-analysis.
Khattiyawittayakun L; Seresirikachorn K; Chitsuthipakorn W; Kanjanawasee D; Snidvongs K
Int Forum Allergy Rhinol; 2018 Dec; 8(12):1445-1453. PubMed ID: 30054985
[TBL] [Abstract][Full Text] [Related]
15. Intranasal Corticosteroid Therapy: Systematic Review and Meta-analysis of Reported Safety and Adverse Effects in Children.
Donaldson AM; Choby G; Kim DH; Marks LA; Lal D
Otolaryngol Head Neck Surg; 2020 Dec; 163(6):1087-1096. PubMed ID: 32660332
[TBL] [Abstract][Full Text] [Related]
16. Intranasal Corticosteroid Therapy: Systematic Review and Meta-analysis of Reported Safety and Adverse Effects in Adults.
Donaldson AM; Choby G; Kim DH; Marks LA; Lal D
Otolaryngol Head Neck Surg; 2020 Dec; 163(6):1097-1108. PubMed ID: 32539494
[TBL] [Abstract][Full Text] [Related]
17. Associations between elevated intraocular pressure and glaucoma, use of glaucoma medications, and 5-year incident cataract: the Blue Mountains Eye Study.
Chandrasekaran S; Cumming RG; Rochtchina E; Mitchell P
Ophthalmology; 2006 Mar; 113(3):417-24. PubMed ID: 16458969
[TBL] [Abstract][Full Text] [Related]
18. Ocular side-effects of topical corticosteroids: what a dermatologist needs to know.
Daniel BS; Orchard D
Australas J Dermatol; 2015 Aug; 56(3):164-9. PubMed ID: 25754554
[TBL] [Abstract][Full Text] [Related]
19. Ocular safety of fluticasone furoate nasal spray in patients with perennial allergic rhinitis: a 2-year study.
LaForce C; Journeay GE; Miller SD; Silvey MJ; Wu W; Lee LA; Chylack LT
Ann Allergy Asthma Immunol; 2013 Jul; 111(1):45-50. PubMed ID: 23806459
[TBL] [Abstract][Full Text] [Related]
20. Local and systemic safety of intranasal corticosteroids.
Sastre J; Mosges R
J Investig Allergol Clin Immunol; 2012; 22(1):1-12. PubMed ID: 22448448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
